152 related articles for article (PubMed ID: 36178342)
1. Fesoterodine Ameliorates Autonomic Dysreflexia While Improving Lower Urinary Tract Function and Urinary Incontinence-Related Quality of Life in Individuals With Spinal Cord Injury: A Prospective Phase IIa Study.
Walter M; Ramirez AL; Lee AHX; Nightingale TE; Rapoport D; Kavanagh A; Krassioukov AV
J Neurotrauma; 2023 May; 40(9-10):1020-1025. PubMed ID: 36178342
[TBL] [Abstract][Full Text] [Related]
2. Protocol for a phase II, open-label exploratory study investigating the efficacy of fesoterodine for treatment of adult patients with spinal cord injury suffering from neurogenic detrusor overactivity for amelioration of autonomic dysreflexia.
Walter M; Ramirez AL; Lee AH; Rapoport D; Kavanagh A; Krassioukov AV
BMJ Open; 2018 Nov; 8(11):e024084. PubMed ID: 30467135
[TBL] [Abstract][Full Text] [Related]
3. Intradetrusor OnabotulinumtoxinA Injections Ameliorate Autonomic Dysreflexia while Improving Lower Urinary Tract Function and Urinary Incontinence-Related Quality of Life in Individuals with Cervical and Upper Thoracic Spinal Cord Injury.
Walter M; Kran SL; Ramirez AL; Rapoport D; Nigro MK; Stothers L; Kavanagh A; Krassioukov AV
J Neurotrauma; 2020 Sep; 37(18):2023-2027. PubMed ID: 32631152
[TBL] [Abstract][Full Text] [Related]
4. Reduction in Bladder-Related Autonomic Dysreflexia after OnabotulinumtoxinA Treatment in Spinal Cord Injury.
Fougere RJ; Currie KD; Nigro MK; Stothers L; Rapoport D; Krassioukov AV
J Neurotrauma; 2016 Sep; 33(18):1651-7. PubMed ID: 26980078
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of fesoterodine for prevention of autonomic dysreflexia in patients with neurogenic dysfunction of the bladder after spinal cord injury].
Salyukov RV; Kamalov AA; Okhobotov DA; Chalyi ME; Frolova MV
Urologiia; 2023 Jul; (3):47-51. PubMed ID: 37417411
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of fesoterodine fumarate (8 mg) in neurogenic detrusor overactivity due to spinal cord lesion or multiple sclerosis: A prospective study.
Konstantinidis C; Samarinas M; Tzitzika M; Kratiras Z; Panagiotakopoulos G; Giannitsas K; Athanasopoulos A
Neurourol Urodyn; 2021 Nov; 40(8):2026-2033. PubMed ID: 34498773
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.
Cruz F; Herschorn S; Aliotta P; Brin M; Thompson C; Lam W; Daniell G; Heesakkers J; Haag-Molkenteller C
Eur Urol; 2011 Oct; 60(4):742-50. PubMed ID: 21798658
[TBL] [Abstract][Full Text] [Related]
8. Intravesical injection of botulinum toxin type a may be an effective treatment option for autonomic dysreflexia in patients with high-level spinal cord injury.
Huang M; Zheng H; Huang T; Yang X; Liu Q; Li Q; Tang P; Xie K; Chen H
J Spinal Cord Med; 2024 Jan; 47(1):74-78. PubMed ID: 36269317
[TBL] [Abstract][Full Text] [Related]
9. Fesoterodine treatment of pediatric patients with neurogenic detrusor overactivity: A 24-week, randomized, open-label, phase 3 study.
Kitta T; Darekar A; Malhotra B; Shahin MH; Jones P; Lindsay M; Mallen S; Nieto A; Crook TJ
J Pediatr Urol; 2023 Apr; 19(2):175.e1-175.e10. PubMed ID: 36504158
[TBL] [Abstract][Full Text] [Related]
10. The therapeutic effects of repeated detrusor injections between 200 or 300 units of onabotulinumtoxinA in chronic spinal cord injured patients.
Chen YC; Kuo HC
Neurourol Urodyn; 2014 Jan; 33(1):129-34. PubMed ID: 23494629
[TBL] [Abstract][Full Text] [Related]
11. OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiology.
Ginsberg D; Cruz F; Herschorn S; Gousse A; Keppenne V; Aliotta P; Sievert KD; Brin MF; Jenkins B; Thompson C; Lam W; Heesakkers J; Haag-Molkenteller C
Adv Ther; 2013 Sep; 30(9):819-33. PubMed ID: 24072665
[TBL] [Abstract][Full Text] [Related]
12. Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity.
Ginsberg D; Gousse A; Keppenne V; Sievert KD; Thompson C; Lam W; Brin MF; Jenkins B; Haag-Molkenteller C
J Urol; 2012 Jun; 187(6):2131-9. PubMed ID: 22503020
[TBL] [Abstract][Full Text] [Related]
13. Combined detrusor-trigone BTX-A injections for urinary incontinence secondary to neurogenic detrusor overactivity.
Hui C; Keji X; Chonghe J; Ping T; Rubiao O; Jianweng Z; Xiangrong D; Liling Z; Maping H; Qingqing L; Qiuling L; Jiebing H; Tanghai H
Spinal Cord; 2016 Jan; 54(1):46-50. PubMed ID: 26261074
[TBL] [Abstract][Full Text] [Related]
14. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.
Schurch B; Stöhrer M; Kramer G; Schmid DM; Gaul G; Hauri D
J Urol; 2000 Sep; 164(3 Pt 1):692-7. PubMed ID: 10953127
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin A injection for the treatment of neurogenic detrusor overactivity secondary to spinal cord injury: multi-institutional experience in Japan.
Sengoku A; Okamura K; Kimoto Y; Ogawa T; Namima T; Yamanishi T; Yokoyama T; Akino H; Maeda Y
Int J Urol; 2015 Mar; 22(3):306-9. PubMed ID: 25403926
[TBL] [Abstract][Full Text] [Related]
16. Supratrigonal cystectomy with Hautmann pouch as treatment for neurogenic bladder in spinal cord injury patients: long-term functional results.
Gobeaux N; Yates DR; Denys P; Even-Schneider A; Richard F; Chartier-Kastler E
Neurourol Urodyn; 2012 Jun; 31(5):672-6. PubMed ID: 22532256
[TBL] [Abstract][Full Text] [Related]
17. Beneficial carry-over effects of chronic at-home genital nerve stimulation on incontinence in individuals with spinal cord injury: A pragmatic trial.
Yeh SD; Khasanah N; Gustafson KJ; Sun C; Tsai ML; Lin BS; Wu CW; Peng CW
Ann Phys Rehabil Med; 2024 Mar; 67(2):101799. PubMed ID: 38128350
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivity.
Chen SF; Kuo HC
J Formos Med Assoc; 2015 Jul; 114(7):583-9. PubMed ID: 24262922
[TBL] [Abstract][Full Text] [Related]
19. AbobotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity regardless of spinal cord injury or multiple sclerosis etiology: Pooled analysis of two phase III randomized studies (CONTENT1 and CONTENT2).
Denys P; Castaño Botero JC; Vita Nunes RL; Wachs B; Mendes Gomes C; Krivoborodov G; Tu LM; Del-Popolo G; Thompson C; Vilain C; Volteau M; Kennelly M;
Neurourol Urodyn; 2023 Jan; 42(1):153-167. PubMed ID: 36321799
[TBL] [Abstract][Full Text] [Related]
20. Prediction of autonomic dysreflexia during urodynamics: a prospective cohort study.
Walter M; Knüpfer SC; Cragg JJ; Leitner L; Schneider MP; Mehnert U; Krassioukov AV; Schubert M; Curt A; Kessler TM
BMC Med; 2018 Apr; 16(1):53. PubMed ID: 29650001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
